Document Detail

Expression of secretagogin in clear-cell renal cell carcinomas associates with a high metastasis rate.
MedLine Citation:
PMID:  21288557     Owner:  NLM     Status:  Publisher    
Renal cell carcinomas are divided into several subgroups according to their histopathologic characteristics. The outcome, therapy responses, and the applicability of molecular-targeted therapies depend on the tumor classification and on the tumor stage. Recent advances within the biomarker research facilitated the exact classification of the molecular character of the renal tumor. For example, the calcium-binding proteins parvalbumin and S-100A1 are characteristically expressed in renal cell carcinoma subgroups. This led us to investigate the expression of the novel calcium-binding protein secretagogin in renal cell carcinomas. Tissue microarray cylinders including 94 clear-cell renal cell carcinomas, 61 non-clear-cell renal cell carcinomas (37 papillary renal cell and 24 chromophobe carcinomas), and 30 oncocytomas were analyzed by immunohistochemistry. This showed remarkable secretagogin expression in 37% of the clear-cell renal cell carcinomas. Non-clear-cell renal cell carcinomas and oncocytomas were completely negative. Consequently performed immunoblotting analyses confirmed this expression profile. Because publicly available data direct toward a formation of a hierarchical cluster of secretagogin overexpressing clear-cell renal cell carcinomas, we conducted a clinical follow-up of the patients with clear-cell renal cell carcinoma. This revealed significantly more metastasis within the secretagogin-positive clear-cell renal cell carcinoma subgroup (49% versus 28%; P < .05). In conclusion, we report on detection of the novel calcium-binding protein secretagogin within a subgroup of clear-cell renal cell carcinomas. The increased metastasis rates within the secretagogin-positive subgroup of clear-cell renal cell carcinomas direct toward a clinical impact of our findings.
Aysegül Ilhan; Dashurie Neziri; Magdalena Maj; Peter R Mazal; Martin Susani; Wolfgang Base; Wolfgang Gartner; Ludwig Wagner
Related Documents :
2580687 - Investigation of a test system for the rapid differentiation of nuclear and cytoplasmic...
3931087 - Inhibition of cell proliferation by d-ribose and deoxy-d-ribose.
11259187 - Hepatitis c virus protein expression induces apoptosis in hepg2 cells.
979077 - Molecular basis of a control mechanism of dna synthesis in mammalian cells.
10089097 - Suitability of cell metabolic colorimetric assays for assessment of cd4+ t cell prolife...
22120277 - Novel animal glioma models that separately exhibit two different invasive and angiogeni...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-31
Journal Detail:
Title:  Human pathology     Volume:  -     ISSN:  1532-8392     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-2-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421547     Medline TA:  Hum Pathol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, A-1090 Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Desquamating apoptotic variant of high-grade prostatic intraepithelial neoplasia: a possible precurs...
Next Document:  RNA-binding protein LIN28 is a marker for testicular germ cell tumors.